-
-
-
-
-
-
-
TherapeuticsMD Announces Full Year 2024 Financial Results
-
-
-
-
-
-
-
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
-
-
-
-
-
-
-
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
-
-
-
-
-
-
-
Form SC TO-T/A TherapeuticsMD, Inc. Filed by: Athene Merger Sub, Inc.
-
-
-
-
-
-
-
Form SC TO-C TherapeuticsMD, Inc. Filed by: Athene Merger Sub, Inc.
-
-
-
-
-
-
-
Karen L. Ling joins Galderma’s Advisory Committee
-
-
-
-
-
-
-
Pre-Open Stock Movers 02/11: (ACIU) (MVIX) (DMTK) Higher; (FLDM) (ELY) (TLRY) Lower (more...)
-
1,187,950 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

